HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesOndansetron
Chemical structure of CAS 99614-02-5

Ondansetron

In Stock•Starting at $21 for 1 g•Purity ≥ 99%
CAS No.99614-02-5
MDL No.MFCD00833882
MFC18H19N3O
MW293.40
InChI KeyFELGMEQIXOGIFQ-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 g99%$21In Stock
5 g99%$72In Stock
25 g99%$280In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Ondansetron is a carbazole compound.

CAS No.99614-02-5
Product NameOndansetron

Biological Targets

HTR3A

Associated Conditions

post operative nausea and vomiting·methamphetamine dependence·Nausea·Dyspnea·Nausea and vomiting·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonists.

Cancer chemotherapy and pharmacology • Vol. 67, Issue 3 • 2011
PMID: 20509026PMC: PMC3043247DOI: 10.1007/s00280-010-1339-4

Clinical trial: oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children--a double-blind randomized study.

Alimentary pharmacology & therapeutics • Vol. 31, Issue 1 • 2010
PMID: 19758398DOI: 10.1111/j.1365-2036.2009.04145.x

Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?

CNS drugs • Vol. 19, Issue 3 • 2005
PMID: 15740177DOI: 10.2165/00023210-200519030-00004

A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis.

Annals of emergency medicine • Vol. 39, Issue 4 • 2002
PMID: 11919526DOI: 10.1067/mem.2002.122706

Documentation

Similar Products